<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36732882</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Evaluating the contribution of the gene TARDBP in Italian patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1246</StartPage><EndPage>1255</EndPage><MedlinePgn>1246-1255</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.15727</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Genetic variants in the gene TARDBP, encoding TDP-43 protein, are associated with amyotrophic lateral sclerosis (ALS) in familial (fALS) and sporadic (sALS) cases. Objectives of this study were to assess the contribution of TARDBP in a large cohort of Italian ALS patients, to determine the TARDBP-associated clinical features and to look for genotype-phenotype correlation and penetrance of the mutations.</AbstractText><AbstractText Label="METHODS">A total of 1992 Italian ALS patients (193 fALS and 1799 sALS) were enrolled in this study. Sanger sequencing of TARDBP gene was performed in patients and, when available, in patients' relatives.</AbstractText><AbstractText Label="RESULTS">In total, 13 different rare variants were identified in 43 index cases (10 fALS and 33 sALS) with a cumulative mutational frequency of 2.2% (5.2% of fALS, 1.8% of sALS). The most prevalent variant was the p.A382T followed by the p.G294V. Cognitive impairment was detected in almost 30% of patients. While some variants, including the p.G294V and the p.G376D, were associated with restricted phenotypes, the p.A382T showed a marked clinical heterogeneity regarding age of onset, survival and association with cognitive impairment. Investigations in parents, when possible, showed that the variants were inherited from healthy carriers and never occurred de novo.</AbstractText><AbstractText Label="CONCLUSIONS">In our cohort, TARDBP variants have a relevant frequency in Italian ALS patients and they are significantly associated with cognitive impairment. Clinical presentation is heterogeneous. Consistent genotype-phenotype correlations are limited to some mutations. A marked phenotypic variability characterizes the p.A382T variant, suggesting a multifactorial/oligogenic pathogenic mechanism.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lattante</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2891-0340</Identifier><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabatelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6635-4985</Identifier><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Neurology, Department of Neuroscience, Faculty of Medicine and Surgery, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisogni</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7314-3393</Identifier><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marangi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doronzio</LastName><ForeName>Paolo Niccol&#xf2;</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martello</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renzi</LastName><ForeName>Anna Gloria</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Giudice</LastName><ForeName>Elda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research &amp; Innovation (R&amp;I Genetics) srl, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>Alberta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research &amp; Innovation (R&amp;I Genetics) srl, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cimbolli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchione</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costantino</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Section of Neurology, Department of Neuroscience, Faculty of Medicine and Surgery, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucioli</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Section of Neurology, Department of Neuroscience, Faculty of Medicine and Surgery, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meleo</LastName><ForeName>Emiliana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patanella</LastName><ForeName>Agata Katia</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Neurology, Department of Neuroscience, Faculty of Medicine and Surgery, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zollino</LastName><ForeName>Marcella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TARDBP</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">clinical heterogeneity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>0</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36732882</ArticleId><ArticleId IdType="doi">10.1111/ene.15727</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197-206. doi:10.1038/nature20413</Citation></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17-23. doi:10.1038/nn.3584</Citation></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572-574. doi:10.1038/ng.132</Citation></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668-1672. doi:10.1126/science.1154584</Citation></Reference><Reference><Citation>Borroni B, Bonvicini C, Alberici A, et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat. 2009;30:E974-E983. doi:10.1002/humu.21100</Citation></Reference><Reference><Citation>Caroppo P, Camuzat A, Guillot-Noel L, et al. Defining the spectrum of frontotemporal dementias associated with TARDBP mutations. Neurol Genet. 2016;2:e80. doi:10.1212/NXG.0000000000000080</Citation></Reference><Reference><Citation>Rayaprolu S, Fujioka S, Traynor S, et al. TARDBP mutations in Parkinson's disease. Parkinsonism Relat Disord. 2013;19:312-315. doi:10.1016/j.parkreldis.2012.11.003</Citation></Reference><Reference><Citation>Chen S, Zhou RL, Zhang W, et al. Novel TARDBP missense mutation caused familial amyotrophic lateral sclerosis with frontotemporal dementia and parkinsonism. Neurobiol Aging. 2021;107:168-173. doi:10.1016/j.neurobiolaging.2021.05.017</Citation></Reference><Reference><Citation>Byrne S, Bede P, Elamin M, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:157-159. doi:10.3109/17482968.2010.545420</Citation></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153-174. doi:10.1080/21678421.2016.1267768</Citation></Reference><Reference><Citation>Kopanos C, Tsiolkas V, Kouris A, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35:1978-1980. doi:10.1093/bioinformatics/bty897</Citation></Reference><Reference><Citation>Lattante S, Conte A, Zollino M, et al. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology. 2012;79:66-72. doi:10.1212/WNL.0b013e31825dceca</Citation></Reference><Reference><Citation>Luquin N, Yu B, Saunderson RB, Trent RJ, Pamphlett R. Genetic variants in the promoter of TARDBP in sporadic amyotrophic lateral sclerosis. Neuromuscul Disord. 2009;19:696-700. doi:10.1016/j.nmd.2009.07.005</Citation></Reference><Reference><Citation>Baralle M, Romano M. Characterization of the human TARDBP gene promoter. Sci Rep. 2021;11:10438. doi:10.1038/s41598-021-89973-z</Citation></Reference><Reference><Citation>Hasegawa-Ogawa M, Okano MJ. Characterization of the upstream and intron promoters of the gene encoding TAR DNA-binding protein. Sci Rep. 2021;11:8720. doi:10.1038/s41598-021-88015-y</Citation></Reference><Reference><Citation>McCann EP, Williams KL, Fifita JA, et al. The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet. 2017;92:259-266. doi:10.1111/cge.12973</Citation></Reference><Reference><Citation>van Blitterswijk M, van Es MA, Hennekam EA, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:3776-3784. doi:10.1093/hmg/dds199</Citation></Reference><Reference><Citation>Li J, Liu Q, Sun X, et al. Genotype-phenotype association of TARDBP mutations in Chinese patients with amyotrophic lateral sclerosis: a single-center study and systematic review of published literature. J Neurol. 2022;269:4204-4212. doi:10.1007/s00415-022-11042-w</Citation></Reference><Reference><Citation>Corrado L, Ratti A, Gellera C, et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat. 2009;30:688-694. doi:10.1002/humu.20950</Citation></Reference><Reference><Citation>Grassano M, Calvo A, Moglia C, et al. Mutational analysis of known ALS genes in an Italian population-based cohort. Neurology. 2021;96:e600-e609. doi:10.1212/WNL.0000000000011209</Citation></Reference><Reference><Citation>Piazza A, Mayr WR, Contu L, et al. Genetic and population structure of four Sardinian villages. Ann Hum Genet. 1985;49:47-63. doi:10.1111/j.1469-1809.1985.tb01675.x</Citation></Reference><Reference><Citation>Orr&#xf9; S, Manolakos E, Orr&#xf9; N, et al. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;81:172-178. doi:10.1111/j.1399-0004.2011.01668.x</Citation></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging. 2014;35:2882.e7-2882.e12. doi:10.1016/j.neurobiolaging.2014.07.012</Citation></Reference><Reference><Citation>Millecamps S, Salachas F, Cazeneuve C, et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;47:554-560. doi:10.1136/jmg.2010.077180</Citation></Reference><Reference><Citation>Guennoc AM, Heuze-Vourc'h N, Gordon PH, et al. Benign lower limb amyotrophy due to TARDBP mutation or post-polio syndrome? Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:476-478. doi:10.3109/21678421.2013.764567</Citation></Reference><Reference><Citation>Corrado L, Pensato V, Croce R, et al. The first case of the TARDBP p.G294V mutation in a homozygous state: is a single pathogenic allele sufficient to cause ALS? Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:273-279. doi:10.1080/21678421.2019.1704011</Citation></Reference><Reference><Citation>Kreiter N, Pal A, Lojewski X, et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol Dis. 2018;115:167-181. doi:10.1016/j.nbd.2018.03.010</Citation></Reference><Reference><Citation>Xu F, Huang S, Li XY, et al. Identification of TARDBP Gly298Ser as a founder mutation for amyotrophic lateral sclerosis in southern China. BMC Med Genet. 2022;15:173. doi:10.1186/s12920-022-01327-4</Citation></Reference><Reference><Citation>Ungaro C, Sprovieri T, Morello G, et al. Genetic investigation of amyotrophic lateral sclerosis patients in South Italy: a two-decade analysis. Neurobiol Aging. 2021;99:99.e7-99.e14. doi:10.1016/j.neurobiolaging.2020.08.017</Citation></Reference><Reference><Citation>Conforti FL, Sproviero W, Simone IL, et al. TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:587-588. doi:10.1136/jnnp.2009.198309</Citation></Reference><Reference><Citation>Benajiba L, Le Ber I, Camuzat A, et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol. 2009;65:470-473. doi:10.1002/ana.21612</Citation></Reference><Reference><Citation>Piaceri I, del Mastio M, Tedde A, et al. Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;82:83-87. doi:10.1111/j.1399-0004.2011.01726.x</Citation></Reference><Reference><Citation>del Bo R, Ghezzi S, Corti S, et al. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol. 2009;16:727-732. doi:10.1111/j.1468-1331.2009.02574.x</Citation></Reference><Reference><Citation>Lattante S, Rouleau GA, Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat. 2013;34:812-826. doi:10.1002/humu.22319</Citation></Reference><Reference><Citation>Czell D, Andersen PM, Morita M, Neuwirth C, Perren F, Weber M. Phenotypes in swiss patients with familial ALS carrying TARDBP mutations. Neurodegener Dis. 2013;12:150-155. doi:10.1159/000345835</Citation></Reference><Reference><Citation>Mitsuzawa S, Akiyama T, Nishiyama A, et al. TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43. eNeurologicalSci. 2018;11:20-22. doi:10.1016/j.ensci.2018.04.001</Citation></Reference><Reference><Citation>Synofzik M, Born C, Rominger A, et al. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease. Neurobiol Aging. 2014;35(1212):e1-e5. doi:10.1016/j.neurobiolaging.2013.10.092</Citation></Reference><Reference><Citation>Gagliardi M, Arabia G, Nistic&#xf2; R, et al. Mutational analysis of TARDBP gene in patients affected by Parkinson's disease from Calabria. J Neurol Sci. 2018;390:209-211. doi:10.1016/j.jns.2018.04.043</Citation></Reference><Reference><Citation>Cannas A, Borghero G, Floris GL, et al. The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms. Neurogenetics. 2013;14:161-166. doi:10.1007/s10048-013-0360-2</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>